Oncology & Cancer

Immunotherapy for brain metastases: Where are we now?

Brain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year. Once diagnosed, patients have a median survival of sic months. Immunotherapy, a type of cancer treatment ...

Oncology & Cancer

Lung cancer therapy may improve outcomes of metastatic brain cancer

A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's ...

Oncology & Cancer

Attacking metastatic tumors in the brain

Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind the ...

page 2 from 4